JP2025513461A5 - - Google Patents
Info
- Publication number
- JP2025513461A5 JP2025513461A5 JP2024562088A JP2024562088A JP2025513461A5 JP 2025513461 A5 JP2025513461 A5 JP 2025513461A5 JP 2024562088 A JP2024562088 A JP 2024562088A JP 2024562088 A JP2024562088 A JP 2024562088A JP 2025513461 A5 JP2025513461 A5 JP 2025513461A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- independently selected
- pharmaceutically acceptable
- compound according
- prodrug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263332450P | 2022-04-19 | 2022-04-19 | |
| US63/332,450 | 2022-04-19 | ||
| PCT/CA2023/050521 WO2023201421A1 (en) | 2022-04-19 | 2023-04-18 | Indoline derivatives as serotonergic agents useful for the treatment of disorders related thereto |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025513461A JP2025513461A (ja) | 2025-04-24 |
| JP2025513461A5 true JP2025513461A5 (enExample) | 2026-04-23 |
Family
ID=88418733
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024562088A Pending JP2025513461A (ja) | 2022-04-19 | 2023-04-18 | セロトニン作動薬としてのインドリン誘導体に関連する障害の治療に有用なセロトニン作動薬としてのインドリン誘導体 |
| JP2024562090A Pending JP2025513462A (ja) | 2022-04-19 | 2023-04-18 | セロトニン作動薬としてのインドリン誘導体に関連する障害の治療に有用なセロトニン作動薬としてのインドリン誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024562090A Pending JP2025513462A (ja) | 2022-04-19 | 2023-04-18 | セロトニン作動薬としてのインドリン誘導体に関連する障害の治療に有用なセロトニン作動薬としてのインドリン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20260083703A1 (enExample) |
| EP (2) | EP4511369A4 (enExample) |
| JP (2) | JP2025513461A (enExample) |
| KR (2) | KR20250036719A (enExample) |
| CN (2) | CN119522212A (enExample) |
| AU (2) | AU2023255414A1 (enExample) |
| CA (2) | CA3248170A1 (enExample) |
| IL (2) | IL316416A (enExample) |
| MX (2) | MX2024012865A (enExample) |
| WO (2) | WO2023201423A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4581028A1 (en) * | 2022-08-29 | 2025-07-09 | Mindset Pharma Inc. | Indoline derivatives as serotonergic agents useful for the treatment of disorders related thereto |
| WO2025104491A1 (en) * | 2023-11-14 | 2025-05-22 | Mindset Pharma Inc. | Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto |
| AU2024397012A1 (en) * | 2023-12-15 | 2026-07-30 | 10763942 Canada Inc. (Dba. Purminds Neuropharma) | Heterocyclic compounds and methods of preparation thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2737725B1 (fr) * | 1995-08-08 | 1997-10-31 | Valentonine | Nouveaux derives acyles de la melatonine et d'analogues melatoninergiques, leur procede de preparation et leur utilisation en tant que medicament |
| CN1289479C (zh) * | 1996-11-26 | 2006-12-13 | Nps艾里利克斯有限公司 | 作为5－ht1d受体配位体的5－环吲哚化合物 |
| JP2003524571A (ja) * | 1997-07-25 | 2003-08-19 | ハー・ルンドベック・アクチエゼルスカベット | インドール−及び２，３−ジヒドロインドール誘導体、その製造方法及びその使用方法 |
| GB9819033D0 (en) * | 1998-09-01 | 1998-10-28 | Cerebrus Ltd | Chemical compounds VI |
| WO2000034266A1 (en) * | 1998-12-11 | 2000-06-15 | Eli Lilly And Company | Indole derivatives and their use as 5-ht1f agonists |
| AU2003236207A1 (en) * | 2002-05-31 | 2003-12-19 | H. Lundbeck A/S | The hydrochloride of (s)-(+)-3-(1-(2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl)-1,2,3,6-tetrahydropyridin-4-yl)-6-chloro-1h-indole |
| WO2005084664A1 (ja) * | 2004-03-08 | 2005-09-15 | Kanazawa University Technology Licensing Organization Ltd. | インドール誘導体及びその用途 |
| JP5452223B2 (ja) * | 2006-07-24 | 2014-03-26 | テトラロジック ファーマシューティカルズ コーポレーション | Ｉａｐ阻害剤 |
| AU2021215709A1 (en) * | 2020-02-04 | 2022-09-01 | Mindset Pharma Inc. | 3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders |
-
2023
- 2023-04-18 JP JP2024562088A patent/JP2025513461A/ja active Pending
- 2023-04-18 EP EP23790806.6A patent/EP4511369A4/en active Pending
- 2023-04-18 EP EP23790804.1A patent/EP4511360A4/en active Pending
- 2023-04-18 AU AU2023255414A patent/AU2023255414A1/en active Pending
- 2023-04-18 WO PCT/CA2023/050523 patent/WO2023201423A1/en not_active Ceased
- 2023-04-18 CA CA3248170A patent/CA3248170A1/en active Pending
- 2023-04-18 CA CA3248179A patent/CA3248179A1/en active Pending
- 2023-04-18 AU AU2023258059A patent/AU2023258059A1/en active Pending
- 2023-04-18 CN CN202380048482.5A patent/CN119522212A/zh active Pending
- 2023-04-18 KR KR1020247038406A patent/KR20250036719A/ko active Pending
- 2023-04-18 IL IL316416A patent/IL316416A/en unknown
- 2023-04-18 KR KR1020247038407A patent/KR20250034020A/ko active Pending
- 2023-04-18 US US18/857,234 patent/US20260083703A1/en active Pending
- 2023-04-18 JP JP2024562090A patent/JP2025513462A/ja active Pending
- 2023-04-18 US US18/857,230 patent/US20250353827A1/en active Pending
- 2023-04-18 WO PCT/CA2023/050521 patent/WO2023201421A1/en not_active Ceased
- 2023-04-18 CN CN202380048473.6A patent/CN119546591A/zh active Pending
- 2023-04-18 IL IL316401A patent/IL316401A/en unknown
-
2024
- 2024-10-17 MX MX2024012865A patent/MX2024012865A/es unknown
- 2024-10-17 MX MX2024012864A patent/MX2024012864A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025513462A5 (enExample) | ||
| ES2935476T3 (es) | Esteroides neuroactivos, composiciones y usos de los mismos | |
| JP2023513679A5 (enExample) | ||
| IL295371A (en) | Psilocyin derivatives as serotonergic psychedelics for the treatment of central nervous system disorders | |
| JP2024508922A5 (enExample) | ||
| US20210113590A1 (en) | Compositions and methods for treating cns disorders | |
| US20210369734A1 (en) | Compounds and methods of their use | |
| IL316401A (en) | Indoline derivatives as estrogenic agents for the treatment of disorders | |
| JP2023553094A5 (enExample) | ||
| JP2023512821A5 (enExample) | ||
| JP2024508545A5 (enExample) | ||
| US20240092824A1 (en) | Compositions and methods for treating cns disorders | |
| JP2019520416A5 (enExample) | ||
| JP6215971B2 (ja) | てんかん又はてんかん−関連症侯群の予防又は治療用フェニルアルキルカルバメート化合物｛ｐｈｅｎｙｌａｌｋｙｌｃａｒｂａｍａｔｅｃｏｍｐｏｕｎｄｓｆｏｒｕｓｅｉｎｐｒｅｖｅｎｔｉｎｇｏｒｔｒｅａｔｉｎｇｅｐｉｌｅｐｓｙｏｒｅｐｉｌｅｐｓｙ−ｒｅｌａｔｅｄｓｙｎｄｒｏｍｅ｝ | |
| ES3041367T3 (en) | Eaat2 activators and methods of using thereof | |
| RU2009103307A (ru) | ПРОИЗВОДНЫЕ ИМИДАЗО[1, 2-a]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В ТЕРАПИИ | |
| EP3030239A2 (en) | Urea derivatives and uses thereof | |
| JP2017523201A5 (enExample) | ||
| RS58053B1 (sr) | [1,2,4] triazolo [1,5-a] pirimidin derivati kao proteazomski inhibitori protozoa za tretman parazitskih bolesti kao što je lišmanijaza | |
| RU2013124827A (ru) | Производные индола и способ их получения | |
| JP2025506201A (ja) | 新規なビシクロペンタン誘導体 | |
| AR034158A1 (es) | Derivados de 1-aminobutano-3-ol sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y el uso de derivados de 1-aminobutano-3-ol sustituidos para la preparacion de medicamentos | |
| JP2019535715A5 (enExample) | ||
| RU2024134395A (ru) | Производные индолина в качестве серотонинергических агентов, подходящих для лечения расстройств, связанных с ними | |
| RU2024134396A (ru) | Производные индолина в качестве серотонинергических агентов, подходящих для лечения расстройств, связанных с ними |